RDNT logo

RadNet Inc. (RDNT)

$73.94

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on RDNT

Market cap

$5.71B

EPS

-0.17

P/E ratio

--

Price to sales

3.09

Dividend yield

--

Beta

1.484261

Price on RDNT

Previous close

$78.66

Today's open

$78.93

Day's range

$73.82 - $79.67

52 week range

$45.00 - $85.84

Profile about RDNT

CEO

Howard G. Berger

Employees

11021

Headquarters

Los Angeles, CA

Exchange

NASDAQ Global Market

Shares outstanding

77282458

Issue type

Common Stock

RDNT industries and sectors

Healthcare

Medical Diagnostics & Screening

News on RDNT

DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow

Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, 1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced today the launch of the DeepHealth Breast Suite, 2 a first-of-its-kind end-to-end suite of modular, interoperable AI-powered applications that address real-world clinical needs across the breast cancer screening and detection pathways. Breast Suite builds on organic innovation and integrated technologies from iCAD to deliver a comprehensive new suite of solutions.

news source

GlobeNewsWire • Dec 1, 2025

news preview

DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care

CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions. The company is announcing new offerings and major enhancements across its portfolio, spanning disease detection, assessment and monitoring, remote scanning, image management and interpretation, center operations and AI orchestration—all designed to transform the imaging experience and advance population health.

news source

GlobeNewsWire • Nov 30, 2025

news preview

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth's Novel AI-Powered Breast Cancer Detection Workflow

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations

news source

GlobeNewsWire • Nov 17, 2025

news preview

GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning

GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities

news source

GlobeNewsWire • Nov 12, 2025

news preview

RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

Acquisition supplements CIMAR's cloud-native infrastructure with DeepHealth's AI-powered informatics to deliver connected, efficient and accessible care

news source

GlobeNewsWire • Nov 11, 2025

news preview

RadNet, Inc. (RDNT) Q3 2025 Earnings Call Transcript

RadNet, Inc. ( RDNT ) Q3 2025 Earnings Call November 10, 2025 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Brian Tanquilut - Jefferies LLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the RadNet Inc. Third Quarter 2025 Financial Results Conference Call.

news source

Seeking Alpha • Nov 10, 2025

news preview

RadNet (RDNT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

news source

Zacks Investment Research • Nov 10, 2025

news preview

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

LOS ANGELES, Nov. 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, today reported financial results for its third quarter of 2025.

news source

GlobeNewsWire • Nov 9, 2025

news preview

Exploring Analyst Estimates for RadNet (RDNT) Q3 Earnings, Beyond Revenue and EPS

Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

news source

Zacks Investment Research • Nov 6, 2025

news preview

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT's Assets

DeepHealth commercializes remote-imaging offering featuring TechLive™ remote scanning and Alpha RT's MRI staffing services, training and safety software.

news source

GlobeNewsWire • Nov 5, 2025

news preview

¹ Disclosures

Get started with M1

Invest in RadNet Inc.

Open an M1 investment account to buy and sell RadNet Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in RDNT on M1